Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating Expenses:        
Research and Development $ 1,628,467 $ 985,880 $ 4,348,631 $ 2,555,035
General and Administrative 1,338,616 1,021,325 3,944,624 3,144,255
Total Operating Expenses 2,967,083 2,007,205 8,293,255 5,699,290
Operating Loss Before Other Expense (2,967,083) (2,007,205) (8,293,255) (5,699,290)
Other Income, Net:        
Gain on Forgiveness of Loan     278,190  
Interest Income 259 331 841 23,115
Interest Expense     (2,719)  
Total Other Income, Net 259 331 276,312 23,115
Net Loss $ (2,966,824) $ (2,006,874) $ (8,016,943) $ (5,676,175)
Net Loss per Common Share - Basic $ (0.29) $ (0.44) $ (0.99) $ (1.25)
Net Loss per Common Share - Diluted $ (0.29) $ (0.44) $ (0.99) $ (1.25)
Weighted-Average Shares Outstanding - Basic 10,265,108 4,547,524 8,101,004 4,536,014
Weighted-Average Shares Outstanding - Diluted 10,265,108 4,547,524 8,101,004 4,536,014
Net Loss $ (2,966,824) $ (2,006,874) $ (8,016,943) $ (5,676,175)
Other Comprehensive Loss:        
Foreign Currency Translation Adjustments (44,734) (17,110) (59,068) (16,944)
Comprehensive Loss $ (3,011,558) $ (2,023,984) $ (8,076,011) $ (5,693,119)